Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API for sale
Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API for sale
Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API for sale
Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API for sale
Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API for sale

Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API Wholesale & Bulk

Introduction of Secukinumab.

Secukinumab is a biologic medication used primarily in the treatment of several autoimmune conditions. It is a monoclonal antibody that targets and inhibits interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of various inflammatory diseases.


Description of Secukinumab from Wuhan Fortuna Chemical Co.,Ltd


Basic   Information of Secukinumab

Product Name

Secukinumab

CAS NO.

875356-43-7

Apperance

Colorless clear liquid

Assay

99.6%

Pacakge

1kg/Foil Bag,25kg/Drum/Box

MOQ

1kg

Storage

Sealed and stored at ≤-30℃

Shelf Life

2 Years

Brand

Fortunachem

Specifications(COA) of High Purity 99.6% Secukinumab Liquid CAS NO 875356-43-7 Active Pharmaceutical Ingredient API


Items

Specifications

Results

Appearance

Colorless   clear liquid

Conform

Concentration  

8.0±0.8mg/ml

8.2mg/ml

pH   value

Corresponds   to reference standard

Pass

Non-reduced   CE-SDS

Main   peak NL.T 90.0%

99.2%

SEC-HPLC

Main   peak NL.T 95.0%

99.6%

Isoelectric   Point

Corresponds   to reference standard

Pass

Bacterial   Endotoxins Test

<15 EU/ml

<1 EU/ml

Residual   Proteins of Host Cell

≤100   ng/mg

<1 ng/mg

Exogenous   Residual DNA

≤100   pg/mg

<1 pg/mg

Residual   protein A

≤100   ng/mg

<1 ng/mg

Biological   Activity

Compared   with standard, the range of biological activity is from 80% to 125%

106%

Osmolality  

Corresponds   to reference standard

Pass

Peptide   mapping

Corresponds   to reference standard

Pass

N-terminal   sequence

Corresponds   to reference standard

Pass

Microbiological   test

Corresponds   to reference standard

Pass

Conclusion

The   product conforms to the standard of CP2010.

Introduction of Secukinumab.

Secukinumab is a biologic medication used primarily in the treatment of several autoimmune conditions. It is a monoclonal antibody that targets and inhibits interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in the pathogenesis of various inflammatory diseases.


Application of Secukinumab.

Secukinumab is a biologic medication primarily used to treat several autoimmune and inflammatory conditions. Its main applications are in the management of diseases where interleukin-17A (IL-17A) plays a significant role in the inflammatory process. Here are the primary applications of Secukinumab:


1. Plaque Psoriasis:

Indication: Secukinumab is approved for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Effectiveness: It helps reduce the scaling, redness, and thickness of psoriatic plaques, leading to significant improvements in skin appearance and patient quality of life.


2. Psoriatic Arthritis:

Indication: Secukinumab is used to treat active psoriatic arthritis in adults.

Effectiveness: It helps reduce joint pain, swelling, and damage, and can improve physical function and quality of life. It is often used in patients who have not responded adequately to other treatments.


3. Ankylosing Spondylitis:

Indication: Secukinumab is approved for the treatment of active ankylosing spondylitis, a type of arthritis that primarily affects the spine.

Effectiveness: It helps reduce inflammation, pain, and stiffness in the spine and other affected areas, improving mobility and quality of life.


4. Non-Radiographic Axial Spondyloarthritis:

Indication: Secukinumab is used for the treatment of non-radiographic axial spondyloarthritis in adults with objective signs of inflammation.

Effectiveness: It helps reduce symptoms such as back pain and stiffness, improving overall function and quality of life.


Conclusion:

Secukinumab is a targeted biologic therapy that has significantly improved the management of several autoimmune conditions by inhibiting IL-17A. Its efficacy in reducing inflammation and improving quality of life for patients with psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis makes it a valuable treatment option. However, like all medications, it requires careful monitoring and consideration of potential side effects.



FAQ   From Wuhan Fortuna Chemical Co.,Ltd

Q

Can I get a sample for   free ?

A

For small QTY and low   value product, we can provide sample for free exclude shipping cost. For high   value sample, we will charge the basic sample cost, but we can refund all the   cost if customers place order after sample test.



Q

How to confirm the product   quality before placing orders ?

A

Most of our products   confirm to international standards like USP/EP/BP/JP/CP. We will provide   COA/TDS/MSDS for customers to confirm the specification before placing order.



Q

What is the payment you   accept?

A

For small and low value   order, we accept CreditCard, MaterCard,VISA,Western Union and T/T.For large   order, we can do T/T and L/C. Any pay on delivery or pay-after are not   available for us.



Q

What is your shipment   way ?

A

For less than 100kg   gross weight order will ship with courier like FedEx or UPS, we support customers to place courier orders   remotely by their account, we will package the goods well and wait for pick   up.For more than 100kg goods, we will transport by Air or Sea according to   customers' requirement.



Q

How long is your after-sales   service?

A

We accept customer’s quality   complaint in three month after customer received the goods. We provide   tech.support for all-life if customer place order from our company.



Q

How do you treat quality complaint ?

A

We support customer to provide our products to any rightful   third party testing organization to test our products according to the COA   specification, if the test result is confirm with COA, we will take all the   loss for customers.

factory-650.jpg

Wuhan Fortuna Chemical Co.,Ltd established in 2006, is a big integrative chemical enterprise being engaged in Pharmaceutical and Intermediates, Food and Feed additives, Fine chemicals,Biochemical and Reagent, which is  the members of Hubei E-commerce Chamber.


Our company has professional persons who major in chemical R&D and sicentific management, supply fine chemical products with high quality and close service, also supply custom-tailored products according to our clients' requirement.


We have a positive and self-motivated management work team with a common philosophy, caring and commitment through teamwork, our team strive to achieve success in delighting our clients and ourselves.


Since Wuhan Fortuna Chemical Co., Ltd founded, we continuously innovate our products and improve our service, sales network. Hence, we initiate the first sale mode on net in China, which is the retail trade of small package bring along wholesale of diversified management modes. Our products are exported widely to South Korea, Vietnam, Australia, Europe and South America, highly recommended by our clients.We insist on the management creed “Market is our compass, Quality is our life, Credit is our soul”. Clients’ trust is our forward power, their satisfaction is our struggling goal.


Wuhan Fortuna Chemical Co.,Ltd is a professional manufacturer which provide Secukinumab with good quality and best price, welcome to contact us to get COA/TDS/MSDS of Secukinumab.

Fortunachem Chemicals
Get In Touch With Fortunachem

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help

Related Active Pharmaceutical Ingredient API Fine Chemicals
MORE
Latest News & Blogs

Keeping you up-to-date with all the latest information, news, and events about Fortunachem!